Richard H. Scheller - 15 Sep 2025 Form 4 Insider Report for Maze Therapeutics, Inc. (MAZE)

Reporting relationship: Director
Issuer ticker: MAZE
Reported as of: 15 Sep 2025
Net transaction value: -$464,035
SEC form: 4
Accepted by SEC: 16 Sep 2025, 16:26:27 UTC
Prior SEC filing: 12 Jun 2025
Next SEC filing: 24 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Courtney Phillips, as attorney-in-fact

Key filing fact

Richard H. Scheller filed Form 4 for Maze Therapeutics, Inc. (MAZE) on 16 Sep 2025.

Key facts

This page summarizes Richard H. Scheller's Form 4 filing for Maze Therapeutics, Inc. (MAZE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Sep 2025, 16:26.

Change

Previous filing in this sequence was filed on 12 Jun 2025.
Current net transaction value: -$464,035.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001214133 Primary reporting owner

SCHELLER RICHARD H

Relationship: Director
Address: C/O MAZE THERAPEUTICS, INC., 171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
Signature: /s/ Courtney Phillips, as attorney-in-fact
Signature date: 16 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MAZE transaction

Common Stock

Sale

Transaction value: $464,035
Shares: -20,744
Change %: -100%
Price: $22.37
Shares after: 0
Date: 15 Sep 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.14 to $22.585, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.